Point72 Asset Management Portfolio holdings
AUM
$42.3B
1-Year Return
23.07%
This Quarter Return
-1.61%
1 Year Return
+23.07%
3 Year Return
+96.14%
5 Year Return
+182.48%
10 Year Return
+383.75%
AUM
$29.4B
AUM Growth
+$431M
(+1.5%)
Cap. Flow
+$1.04B
Cap. Flow
% of AUM
3.54%
Top 10 Holdings %
Top 10 Hldgs %
13.49%
Holding
2,326
New
613
Increased
589
Reduced
429
Closed
466
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$278M |
| 2 |
Arista Networks
ANET
|
$213M |
| 3 |
Boeing
BA
|
$204M |
| 4 |
Qiagen
QGEN
|
$177M |
| 5 |
Kenvue
KVUE
|
$166M |
Top Sells
| 1 |
Adobe
ADBE
|
$355M |
| 2 |
AutoZone
AZO
|
$242M |
| 3 |
Dominion Energy
D
|
$186M |
| 4 |
Palo Alto Networks
PANW
|
$185M |
| 5 |
Marathon Petroleum
MPC
|
$183M |
Sector Composition
| 1 | Technology | 20.26% |
| 2 | Healthcare | 19.48% |
| 3 | Consumer Discretionary | 12.41% |
| 4 | Industrials | 10.27% |
| 5 | Energy | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Elanco Animal Health
ELAN
$9.16B
| $40.5M | 0.12% |
3,599,461
+447,460
| +14% | +$5.03M |
|
202
CenterPoint Energy
CNP
$24.7B
| $40.2M | 0.12% |
1,497,930
+1,496,248
| +88,956% | +$40.2M |
|
203
Evolent Health
EVH
$1.11B
| $40.2M | 0.12% |
+1,475,600
| New | +$40.2M |
|
204
Glaukos
GKOS
$5.39B
| $40.1M | 0.12% |
533,339
-136,509
| -20% | -$10.3M |
|
205
Fidelity National Information Services
FIS
$35.9B
| $39.8M | 0.12% |
720,675
-1,585,194
| -69% | -$87.6M |
|
206
Akamai
AKAM
$11.3B
| $39.3M | 0.11% |
369,092
+367,476
| +22,740% | +$39.2M |
|
207
Health Catalyst
HCAT
$238M
| $39.3M | 0.11% |
3,883,852
+1,486,596
| +62% | +$15M |
|
|
SIX
208
DELISTED
Six Flags Entertainment Corp.
SIX
| $39.3M | 0.11% |
1,671,460
+1,523,411
| +1,029% | +$35.8M |
|
209
Reinsurance Group of America
RGA
$12.8B
| $38.7M | 0.11% |
266,448
+226,046
| +559% | +$32.8M |
|
210
FTAI Aviation
FTAI
$15.8B
| $38.6M | 0.11% |
1,086,555
+600,872
| +124% | +$21.4M |
|
211
Xenon Pharmaceuticals
XENE
$3.02B
| $38.5M | 0.11% |
1,125,708
+977,500
| +660% | +$33.4M |
|
212
Steris
STE
$24.2B
| $38.4M | 0.11% |
175,130
+139,949
| +398% | +$30.7M |
|
213
Sunrun
RUN
$4.19B
| $38.3M | 0.11% |
3,050,722
+2,021,834
| +197% | +$25.4M |
|
214
Centene
CNC
$14.2B
| $38.1M | 0.11% |
553,384
+94,927
| +21% | +$6.54M |
|
215
IAC Inc
IAC
$2.98B
| $37.9M | 0.11% |
+917,054
| New | +$37.9M |
|
216
Marsh & McLennan
MMC
$100B
| $37.8M | 0.11% |
198,707
-137,973
| -41% | -$26.3M |
|
217
Structure Therapeutics
GPCR
$1.27B
| $37.7M | 0.11% |
747,100
+316,100
| +73% | +$15.9M |
|
218
MasTec
MTZ
$14B
| $37.5M | 0.11% |
520,661
+28,661
| +6% | +$2.06M |
|
219
Chord Energy
CHRD
$5.92B
| $37.4M | 0.11% |
231,056
+171,556
| +288% | +$27.8M |
|
220
Sarepta Therapeutics
SRPT
$1.96B
| $37.3M | 0.11% |
307,343
-22,026
| -7% | -$2.67M |
|
221
Axsome Therapeutics
AXSM
$6.25B
| $37.2M | 0.11% |
531,937
+63,934
| +14% | +$4.47M |
|
|
AXNX
222
DELISTED
Axonics, Inc. Common Stock
AXNX
| $37M | 0.11% |
658,695
+600,821
| +1,038% | +$33.7M |
|
223
Celldex Therapeutics
CLDX
$1.52B
| $36.9M | 0.11% |
1,342,400
+157,600
| +13% | +$4.34M |
|
224
Micron Technology
MU
$147B
| $36.9M | 0.11% |
542,049
-2,282,951
| -81% | -$155M |
|
225
Maximus
MMS
$4.97B
| $36.8M | 0.11% |
493,300
+242,093
| +96% | +$18.1M |
|